772 datasets found

Nasal And Systemic Immunity following COvid VACcination (NASI-COVAC)

BCG vaccination to minimise COVID-19 disease severity and duration

Kansen in Crisis: Hoe geven scholen vorm aan educatief partnerschap?; Chances in Crisis: How do schools shape school-family partnerships?

The impact of COVID-19 on children and adolescents with Autism Spectrum Disorder (ASD) and their families; Impact van COVID-19 op kinderen en jongeren met autismespectrum...

The impact of COVID-19 on illiterate people and people with a mild intellectual disabilities: preventative measures, (mental) health and support needs.

ANAkinra voor de behandeling van CORonavirus infectious disease 2019 op de Intensive Care (ANACOR-IC)

Providing context to excess mortality through changes in healthcare use during the COVID-19 pandemic

A double-blind, placebo-controlled randomized clinical trial with valsartan for PRevention of Acute rEspiraTORy dIstress syndrome in hospitAlized patieNts with SARS-COV-2...

Waarderend onderzoeken en ontwikkelen: leidt de toepassing van deze interventie in de teams van de Stichting Jeugdgezondheidszorg Zuid-Holland West tot het versterken en...

Ethiek van e-Health tijdens de coronacrisis en daarna: lessen uit de pandemie

SARSLIVA: utility of saliva in COVID-19 diagnosis - a household study

Immunity against SARS-CoV-2 in immune-suppressed patients: increased risk of insufficient immunological memory or sufficient protection against re-infection a a Target to B!...

Employing a physiological microfluidic lung bioreactor to improve understanding of SARS-CoV2 biology and testing of therapeutics

A Phase I-II study of virus neutralizing antibodies against SARS-CoV-2. A focus on convalescent plasma and hyperimmune anti-SARS-CoV-2 immunoglobulines

Safety and efficacy of SARS-CoV-2 antibodies

Establishment and duration of protective immunity against SARS-CoV-2 in relation to severity of SARS-CoV-2 infection.; Establishment and duration of protective immunity against...

Convalescent plasma as a treatment for high-risk outpatients administered within 7 days after COVID-19 disease onset (CoV-Early)

Voorkomen van verspreiding van infectieziekten: Een Serious Game

Ethnicity and COVID-19: epidemiology and control measures

Interventie implementatie op beleids- en organisatieniveau in verschillende arbeidsorganisaties gericht op een duurzame gedragsverandering, vanuit eigen regie, voor het...